Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-16
2011-08-16
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S217050, C514S228200, C514S230200, C540S544000, C540S599000, C544S060000, C544S063000, C544S089000, C544S101000
Reexamination Certificate
active
07998951
ABSTRACT:
The invention encompasses compounds of Formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
REFERENCES:
patent: 7153848 (2006-12-01), Hudyma et al.
patent: 7348425 (2008-03-01), Hudyma et al.
patent: 2007/0060565 (2007-03-01), Meanwell et al.
patent: 2007/0078122 (2007-04-01), Bergstrom et al.
patent: 2007/0184024 (2007-08-01), Meanwell et al.
patent: 2007/0185083 (2007-08-01), Bergstrom et al.
patent: 2007/0270405 (2007-11-01), Bender et al.
patent: 2007/0270406 (2007-11-01), Gentles et al.
patent: 2007/0275930 (2007-11-01), Gentles et al.
patent: 2007/0275947 (2007-11-01), Bergstrom
patent: 2007/0287694 (2007-12-01), Yeung et al.
patent: WO 2005/080399 (2005-09-01), None
patent: WO 2006/046030 (2006-05-01), None
patent: WO 2006/046039 (2006-05-01), None
patent: WO 2007/029029 (2007-03-01), None
patent: WO 2007/129119 (2007-11-01), None
U.S. Appl. No. 12/022,541, filed Jan. 30, 2008, Kap-Sun Yeung et al.
U.S. Appl. No. 12/046,030, filed Mar. 11, 2008, Kap-Sun Yeung et al.
U.S. Appl. No. 12/039,239, filed Feb. 28, 2008, Robert G. Gentles et al.
U.S. Appl. No. 12/045,874, filed Mar. 11, 2008, Robert G. Gentles et al.
U.S. Appl. No. 12/045,766, filed Mar. 11, 2008, John A. Bender et al.
U.S. Appl. No. 12/031,844, filed Feb. 15, 2008, Andrew Nickel et al.
U.S. Appl. No. 12/046,286, filed Mar. 11, 2008, Piyasena Hewawasam et al.
U.S. Appl. No. 11/942,285, filed Nov. 19, 2007, John A. Bender et al.
U.S. Appl. No. 11/971,362, filed Jan. 9, 2008, John A. Bender et al.
Kadow John F.
Yeung Kap-Sun
Bristol--Myers Squibb Company
Coleman Brenda
Epperson James
LandOfFree
HCV NS5B inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HCV NS5B inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HCV NS5B inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2708156